Literature DB >> 10575129

Respiratory viral infection predisposing for bacterial disease: a concise review.

J M Hament1, J L Kimpen, A Fleer, T F Wolfs.   

Abstract

Although bacterial superinfection in viral respiratory disease is a clinically well documented phenomenon, the pathogenic mechanisms are still poorly understood. Recent studies have revealed some of the mechanisms involved. Physical damage to respiratory cells as a result of viral infection may lead to opportunistic adherence of bacteria. Enhanced bacterial adherence by specific mechanisms has been documented for respiratory cells infected with influenza A virus, respiratory syncytial virus and adenovirus in both in vitro and in vivo models. To date, results of various experimental studies indicate that different mechanisms for increased bacterial adherence induced by viruses are operating for specific viral-bacterial combinations. In the present review, a number of key findings obtained during the past two decades is presented and discussed.

Entities:  

Mesh:

Year:  1999        PMID: 10575129     DOI: 10.1111/j.1574-695X.1999.tb01389.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  119 in total

1.  Respiratory syncytial virus infection and invasive meningococcal disease: is there an association?

Authors:  Martin C J Kneyber; Adrianus J van Vught
Journal:  Eur J Pediatr       Date:  2003-03-06       Impact factor: 3.183

2.  Pulmonary bacterial co-infection in children ventilated for severe respiratory syncytial virus bronchiolitis is common.

Authors:  Kentigern Thorburn; Hendrik Van Saene
Journal:  Intensive Care Med       Date:  2006-12-20       Impact factor: 17.440

3.  Transcriptional regulation of lipopolysaccharide (LPS)-induced Toll-like receptor (TLR) expression in murine macrophages: role of interferon regulatory factors 1 (IRF-1) and 2 (IRF-2).

Authors:  Quan M Nhu; Natalia Cuesta; Stefanie N Vogel
Journal:  J Endotoxin Res       Date:  2006

4.  Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner.

Authors:  Vasanthi Avadhanula; Carina A Rodriguez; John P Devincenzo; Yan Wang; Richard J Webby; Glen C Ulett; Elisabeth E Adderson
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Palivizumab, pneumococcal and influenza vaccination in cystic fibrosis.

Authors:  Mukta Jain; Anne H Thomson
Journal:  J R Soc Med       Date:  2009-07       Impact factor: 5.344

Review 6.  The airway epithelium: soldier in the fight against respiratory viruses.

Authors:  Marjolaine Vareille; Elisabeth Kieninger; Michael R Edwards; Nicolas Regamey
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 7.  Use of vaccines as probes to define disease burden.

Authors:  Daniel R Feikin; J Anthony G Scott; Bradford D Gessner
Journal:  Lancet       Date:  2014-02-17       Impact factor: 79.321

Review 8.  Viral lower respiratory tract infection in infants and young children.

Authors:  J B M van Woensel; W M C van Aalderen; J L L Kimpen
Journal:  BMJ       Date:  2003-07-05

9.  High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis.

Authors:  K Thorburn; S Harigopal; V Reddy; N Taylor; H K F van Saene
Journal:  Thorax       Date:  2006-03-14       Impact factor: 9.139

10.  Validation of syndromic surveillance for respiratory pathogen activity.

Authors:  Cees van den Wijngaard; Liselotte van Asten; Wilfrid van Pelt; Nico J D Nagelkerke; Robert Verheij; Albert J de Neeling; Arnold Dekkers; Marianne A B van der Sande; Hans van Vliet; Marion P G Koopmans
Journal:  Emerg Infect Dis       Date:  2008-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.